Posts


 |



Study explains why HIV sometimes persists in blood post-treatment

... antiretroviral drug therapy. These samples, which were assessed from 32 ... Modern antiretroviral therapies, which date back to 1996, prevent ... View article...

Will HIV Win and Lung Cancer Loss in Trials Recast Merck's (MRK) Risk Reward Narrative?

In early June 2026, Gilead Sciences and Merck reported that their investigational once-weekly oral HIV regimen of islatravir/lenacapavir met the ... View article...

HIV integration must not come at the cost of access, experts warn

Hundreds of thousands of Ugandans were living with HIV and not on antiretroviral medication then, and concerns were that a US executive order ... View article...

Highly effective prevention drug arrives in South Africa, which has world's highest HIV burden

 Growing up witnessing the devastating effects of HIV in her family and community in South Africa pushed Olwam ... View article...

Most cases of HIV persistence in blood following treatment explained by defective copies of the virus

A study based on blood samples strongly suggests that most persistent cases of viral detection, despite ideal HIV drug therapy, are not due to ... View article...

South Africa moves to eliminate HIV threat with Lenacapavir rollout

Making the HIV prevention medicine available to South Africans was one of the commitments the President made in the State of the Nation Address (SONA) ... View article...

5′ Leader Defects Fuel Persistent HIV-1 Viremia

A Groundbreaking Discovery Unveils Why HIV -1 Viremia Persists Despite Long-Term Antiretroviral Therapy For decades, the scientific community has ... View article...

Philippines secures 15,000 doses of injectable prep amid rising HIV infections

... Lenacapavir (LEN) through a joint initiative with the United States Department of State to combat the country's rising HIV infection rates. View article...